Commonly Utilized Radiopharmaceuticals Flashcards
(39 cards)
Diagnosis of pernicious anemia and intestinal absorption deficiencies.
Co-57 Vitamin B12 (DNI)
Most commonly used for red cell mass and survival. Also used for splenic sequestration studies. Non-imaging in vitro assay via counting serial blood samples.
Cr-51 Sodium Chromate
RBCS (DNI)
Major clinical application in oncology imaging. Used to assess recurrence and to differentiate between recurring tumor and necrotic tissue. Also used for the localization of epileptogenic focus and evaluation of dementias. Cardiac applications in determining metabolic activity and viability of myocardium.
F-18 Fluorodeoxyglúcose
(DI)
Bone scan. Uptake of ____ reflects blood flow and bone remodeling. The CT component of PET/CT systems have significantly improved the specificity, allowing for morphologic characterization of the functional lesions and more accurate differentiation between benign lesions and metastases.
F-18 Sodium fluoride (DI)
Tumor, abscess imaging;
Hodgkin’s disease; lymphoma, and acute inflammatory lesions.
Interstitial lung diseases and fever of unknown origin.
Ga-67 Citrate (Di)
Brain SPECT for dopamine transporter allows visualization of brain striata to evaluate patients with suspected parkinsonian syndromes. Helps differentiate essential tremor from tremor due to Parkinson’s.
I-123 ioflupane also known as DaTscan (DI)
Detection of primary or metastatic pheochromocytoma
or neuroblastoma.
1-123 Metaiodobenzylguanidine MIBG (DI)
Evaluation of thyroid function and/or morphology. Uptake determined by Nal (TI) thyroid probe
1-123 Sodium lodide (DI
& DNI
Blood and plasma volume determinations.
1-125 Albumin (DNI)
-370 kBq (-10 uCi) used for uptake studies (DNI).
-74-185 MBq (~2-5 mCi) for diagnostic thyroid carcinoma metastatic survey.
-185-555 MBq (~5-15 mCi) or hyperthyroidism therapy.
-1.1-7.4 GBq (-30-200 mCi) for thyroid carcinoma therapy.
1-131 Sodium lodide. (DI, DNI, T)
Radioimmunotherapic monoclonal antibody for the treatment of chemotherapy-refractory low-grade or transformed low-grade
Non-Hodgkin’s Lymphoma
I-131 Tositumomab also known as Bexxar (T)
Indicated for patients with biopsy proven prostate cancer that is thought to be clinically localized following standard diagnostic imaging tests. Also indicated in postprostatectomy patients with high clinical suspicion of occult metastatic disease.
In-111 Capromab Pendetide also known as ProstaScint (DI)
Localization of primary and metastatic neuroendocrine tumors bearing the somatostatin receptor.
In-111 Pentetreotide also known as as Octreoscan (DI)
Detection of occult inflammatory lesions not visualized by other modalities. Confirmation of active infection in a known area. Careful isolation and labeling of WBC’s is essential to maintain cell viability labeling efficiency -80%. Better for deep abscesses or vertebral osteomyelitis than Tc-99m WBC
In-111 White Blood Cells (DI)
Lung ventilation studies; however, availability of generator is limitied due to short parent. Used infrequently due to expense for the generator.
Kr-81m Kypton Gas (DI)
Instilled directly into the body cavity containing a malignant effusion. Dose range (IP) 370-740 MBq (10-20 mCi) (IPL)
222-444 MBq (6-12 mCi).
P-32 Chromic Phosphate
Colloid (T)
Treatment of polycythemia vera (PCV) most common; also myelocytic leukemia, chronic lymphocytic leukemia.
P-32 Sodium Phosphate (T)
Myocardial perfusion agent that is useful in distinguishing normal from abnormal myocardium in patients with suspected myocardial infarction.
Short half life allows rest and stress to be performed in less than 1 h.
Rb-82 also known as CardioGen-82 (DI)
Therapy only. Indicated for the palliative relief of bone pain in patients with painful skeletal metastases. Beta and gamma. Gamma allows imaging if desired.
Sm-153 EDTMP also known as Quadramet (T)
Therapy only. Indicated for the palliative relief of bone pain in patients with painful skeletal metastases. Beta and gamma. Pure beta so radiation safety concerns for caregivers are less than for Sm-153
Sr-89 Chloride also known as Metastron (T)
Hepatobiliary imaging agent, hepatic duct and gallbladder visualization occurs -20 min after administration as liver activity decreases.
Tc-99m Disofenin also known as HIDA (DI)
Evaluation of renal parenchymal disorders
Tc-99m DMSA (dimercaptosuccinic acid)
also known as Succimer (DI
Ceretec is used to radiolabel leukocytes as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease. Good for superficial lesions such as diabetic ulcers. Also used in detection of altered regional cerebral perfusion in stroke, Alzheimer’s disease, seizures, etc.
Tc-99m Exametazime also known as Ceretac and HMPAO (DI)
Scintigraphic evaluation of pulmonary perfusion. -0.6 million (range 0.2-1.2) particles are injected with an adult dose. Not be used in patients with severe pulmonary hypertension or history of hypersensitivity to human serum albumin. Also used to assess liver perfusion before chemoembolization or sphere therapy.
Tc-99m Macro aggregated
albumin (MAA) (DI)